Study identifier:D0816R00013
ClinicalTrials.gov identifier:NCT03229122
EudraCT identifier:N/A
CTIS identifier:N/A
Japan CHARLOTTE: Characterizing the cross-sectional approach to Ovarian cancer: Genetic testing of BRCA
ovarian cancer
N/A
No
-
Female
446
Observational
20 Years - 130 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: Open Label
Primary Purpose: -
Verified 01 Jun 2019 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|